110 related articles for article (PubMed ID: 21709345)
1. Experimental verification of IMPT treatment plans in an anthropomorphic phantom in the presence of delivery uncertainties.
Albertini F; Casiraghi M; Lorentini S; Rombi B; Lomax AJ
Phys Med Biol; 2011 Jul; 56(14):4415-31. PubMed ID: 21709345
[TBL] [Abstract][Full Text] [Related]
2. Introducing an on-line adaptive procedure for prostate image guided intensity modulate proton therapy.
Zhang M; Westerly DC; Mackie TR
Phys Med Biol; 2011 Aug; 56(15):4947-65. PubMed ID: 21772078
[TBL] [Abstract][Full Text] [Related]
3. The influence of the optimization starting conditions on the robustness of intensity-modulated proton therapy plans.
Albertini F; Hug EB; Lomax AJ
Phys Med Biol; 2010 May; 55(10):2863-78. PubMed ID: 20427853
[TBL] [Abstract][Full Text] [Related]
4. Is it necessary to plan with safety margins for actively scanned proton therapy?
Albertini F; Hug EB; Lomax AJ
Phys Med Biol; 2011 Jul; 56(14):4399-413. PubMed ID: 21709340
[TBL] [Abstract][Full Text] [Related]
5. A robust algorithm of intensity modulated proton therapy for critical tissue sparing and target coverage.
Inaniwa T; Kanematsu N; Furukawa T; Hasegawa A
Phys Med Biol; 2011 Aug; 56(15):4749-70. PubMed ID: 21753233
[TBL] [Abstract][Full Text] [Related]
6. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties.
Lomax AJ
Phys Med Biol; 2008 Feb; 53(4):1027-42. PubMed ID: 18263956
[TBL] [Abstract][Full Text] [Related]
7. Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques.
Liu W; Li Y; Li X; Cao W; Zhang X
Med Phys; 2012 Jun; 39(6):3089-101. PubMed ID: 22755694
[TBL] [Abstract][Full Text] [Related]
8. Uncertainty reduction in intensity modulated proton therapy by inverse Monte Carlo treatment planning.
Morávek Z; Rickhey M; Hartmann M; Bogner L
Phys Med Biol; 2009 Aug; 54(15):4803-19. PubMed ID: 19622848
[TBL] [Abstract][Full Text] [Related]
9. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
10. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans.
Stuschke M; Kaiser A; Pöttgen C; Lübcke W; Farr J
Radiother Oncol; 2012 Jul; 104(1):45-51. PubMed ID: 22560714
[TBL] [Abstract][Full Text] [Related]
11. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions.
Lomax AJ
Phys Med Biol; 2008 Feb; 53(4):1043-56. PubMed ID: 18263957
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of intensity modulated proton therapy plans to changes in patient weight.
Albertini F; Bolsi A; Lomax AJ; Rutz HP; Timmerman B; Goitein G
Radiother Oncol; 2008 Feb; 86(2):187-94. PubMed ID: 18199516
[TBL] [Abstract][Full Text] [Related]
13. Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy.
Pflugfelder D; Wilkens JJ; Oelfke U
Phys Med Biol; 2008 Mar; 53(6):1689-700. PubMed ID: 18367797
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
15. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
16. Increasing maximum tumor dose to manage range uncertainties in IMPT treatment planning.
Petit S; Seco J; Kooy H
Phys Med Biol; 2013 Oct; 58(20):7329-41. PubMed ID: 24077105
[TBL] [Abstract][Full Text] [Related]
17. Temporal characterization and in vitro comparison of cell survival following the delivery of 3D-conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT).
McGarry CK; Butterworth KT; Trainor C; O'Sullivan JM; Prise KM; Hounsell AR
Phys Med Biol; 2011 Apr; 56(8):2445-57. PubMed ID: 21427488
[TBL] [Abstract][Full Text] [Related]
18. 3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID.
van Zijtveld M; Dirkx ML; de Boer HC; Heijmen BJ
Radiother Oncol; 2007 Feb; 82(2):201-7. PubMed ID: 17287039
[TBL] [Abstract][Full Text] [Related]
19. Accounting for range uncertainties in the optimization of intensity modulated proton therapy.
Unkelbach J; Chan TC; Bortfeld T
Phys Med Biol; 2007 May; 52(10):2755-73. PubMed ID: 17473350
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric verification of RapidArc treatment delivery.
Korreman S; Medin J; Kjaer-Kristoffersen F
Acta Oncol; 2009; 48(2):185-91. PubMed ID: 18777411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
